A conversation with Dr. Thomas Lynch, Fred Hutch President
Join us on Thursday, May 21, for a conversation with Dr. Thomas Lynch, the new president of Seattle’s Fred Hutchinson Cancer Research Center, whose scientists and researchers have emerged as leaders in the effort to understand, track and reduce the spread of COVID-19 in the midst of the global pandemic. Learn about the latest in developments in COVID-19, plus the status of the organization’s core cancer research efforts, and Dr. Lynch’s long-term vision for Fred Hutch as a research institution. Participation in this webinar is exclusive to GeekWire members.
Become a GeekWire member today!
Dr. Thomas Lynch is president and director of the Fred Hutchinson Cancer Research Center, the sixth president in the 44-year history of the Seattle-based research institution, which employs more than 3,000 people and is ranked first in National Institutes of Health funding among all U.S. independent research centers.
He’s a scientist and oncologist who was part of the first research team to discover how targeted therapies could help lung cancer patients with a specific genetic mutation. Dr. Lynch was most recently chief scientific officer of Bristol-Myers Squibb. Prior to that he held leadership roles as CEO of Massachusetts General Physicians Organization, director of Yale Cancer Center, physician-in-chief at Yale’s Smilow Cancer Hospital, chief of hematology-oncology at Massachusetts General Hospital and professor of medicine at Harvard Medical School.